Francesco Tannura: The Potential of the Khorana Risk Score for PE Stratification in Lung Cancer
Francesco Tannura, Clinical Fellow at Ramón y Cajal University Hospital, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Cancers MDPI, adding:
”I am pleased to announce that our work, titled ‘Pulmonary Embolism in Patients with Lung Cancer: Incidence and Performance of Prognostic Markers’, has just been published in Cancers (Cancers MDPI).
This research evaluates the performance of current risk stratification models for pulmonary embolism in lung cancer patients, and explores the potential of the Khorana Risk Score.
I am grateful to my supervisors, for their support and guidance throughout this journey (Roberta Pancani, Alessandro Celi, Laura Carrozzi).
This publication marks an important milestone for me, providing a solid foundation for my current research field.”
Title: Pulmonary Embolism in Patients with Lung Cancer: Incidence and Performance of Prognostic Markers
Authors: Francesco Tannura, Andrea Sbrana, Antonio Chella, Francesco Pistelli, Laura Carrozzi, Alessandro Celi, Roberta Pancani

Stay updated on all scientific advances with Hemostasis Today.
-
Jul 21, 2026, 08:43Joy Duemke: Optimizing Stem Cell Collection for Gene Therapy Success
-
Jul 21, 2026, 07:55A New Era of Precision Imaging for Venous Thromboembolism – JTH
-
Jul 21, 2026, 07:43How to Monitor and Manage Unfractionated Heparin in Practice – JTH
-
Jul 21, 2026, 07:23Arthur Allen: Advancing Outpatient Antithrombotic Stewardship Through ADAPT
-
Jul 21, 2026, 03:19Where Does Stroke Treatment Go Next on The Latest ESOC 2026 TV Studio Session – ESO
-
Jul 21, 2026, 03:09Francesca Palandri: New Insights Into Anemia Management in Myelofibrosis
-
Jul 21, 2026, 01:57A New Approach to Understanding Plasmin Generation and Fibrinolysis – RPTH Journal
-
Jul 21, 2026, 01:52Maria Diaz Alonso: Delivering My First International Oral Presentation at ISTH 2026
-
Jul 21, 2026, 01:44Megan Preece: Presenting New Research on Antiphospholipid Syndrome at ISTH 2026